219 related articles for article (PubMed ID: 12042656)
1. T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice.
Weetall M; Digan ME; Hugo R; Mathew S; Hopf C; Tart-Risher N; Zhang J; Shi V; Fu F; Hammond-McKibben D; West S; Brack R; Brinkmann V; Bergman R; Neville D; Lake P
Transplantation; 2002 May; 73(10):1658-66. PubMed ID: 12042656
[TBL] [Abstract][Full Text] [Related]
2. A new reagent for the induction of T-cell depletion, anti-CD3-CRM9.
Neville DM; Scharff J; Hu HZ; Rigaut K; Shiloach J; Slingerland W; Jonker M
J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):85-92. PubMed ID: 8732691
[TBL] [Abstract][Full Text] [Related]
3. Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion.
Thompson J; Stavrou S; Weetall M; Hexham JM; Digan ME; Wang Z; Woo JH; Yu Y; Mathias A; Liu YY; Ma S; Gordienko I; Lake P; Neville DM
Protein Eng; 2001 Dec; 14(12):1035-41. PubMed ID: 11809934
[TBL] [Abstract][Full Text] [Related]
4. Effect of pre-existing anti-diphtheria toxin antibodies on T cell depletion levels following diphtheria toxin-based recombinant anti-monkey CD3 immunotoxin treatment.
Matar AJ; Pathiraja V; Wang Z; Duran-Struuck R; Gusha A; Crepeau R; Tasaki M; Sachs DH; Huang CA
Transpl Immunol; 2012 Aug; 27(1):52-4. PubMed ID: 22676970
[TBL] [Abstract][Full Text] [Related]
5. Treatment with immunotoxin.
Knechtle SJ
Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):681-9. PubMed ID: 11375071
[TBL] [Abstract][Full Text] [Related]
6. Immunotoxin FN18-CRM9 induces stronger T cell signaling than unconjugated monoclonal antibody FN18.
Hamawy MM; Tsuchida M; Cho CS; Manthei ER; Fechner JH; Knechtle SJ
Transplantation; 2001 Aug; 72(3):496-503. PubMed ID: 11502982
[TBL] [Abstract][Full Text] [Related]
7. In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment.
Blazar BR; Hirsch R; Gress RE; Carroll SF; Vallera DA
J Immunol; 1991 Sep; 147(5):1492-503. PubMed ID: 1831826
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of tolerance induced by an immunotoxin against CD3 epsilon in a rhesus kidney allograft model.
Fechner JH; Vargo DJ; Geissler EK; Wang J; Neville DM; Knechtle SJ
Transplant Proc; 1997; 29(1-2):1158. PubMed ID: 9123249
[No Abstract] [Full Text] [Related]
9. Split tolerance induced by immunotoxin in a rhesus kidney allograft model.
Fechner JH; Vargo DJ; Geissler EK; Graeb C; Wang J; Hanaway MJ; Watkins DI; Piekarczyk M; Neville DM; Knechtle SJ
Transplantation; 1997 May; 63(9):1339-45. PubMed ID: 9158030
[TBL] [Abstract][Full Text] [Related]
10. Influence of relative binding affinity on efficacy in a panel of anti-CD3 scFv immunotoxins.
Hexham JM; Dudas D; Hugo R; Thompson J; King V; Dowling C; Neville DM; Digan ME; Lake P
Mol Immunol; 2001 Sep; 38(5):397-408. PubMed ID: 11684296
[TBL] [Abstract][Full Text] [Related]
11. The effect of anti-CD3-immunotoxin on T lymphocyte function in vitro.
Meng G; Jiang Y; Hubbard W; Thomas JM
Transpl Immunol; 1998 Mar; 6(1):53-9. PubMed ID: 9640629
[TBL] [Abstract][Full Text] [Related]
12. Primate renal transplants using immunotoxin.
Knechtle SJ; Fechner JH; Dong Y; Stavrou S; Neville DM; Oberley T; Buckley P; Armstrong N; Rusterholz K; Hong X; Tsuchida M; Hamawy MM
Surgery; 1998 Aug; 124(2):438-46; discussion 446-7. PubMed ID: 9706169
[TBL] [Abstract][Full Text] [Related]
13. Reversal of acute allograft rejection using immunotoxin.
Knechtle SJ; Fechner JH; Stavrou S; Neville DM; Dong Y; Hong X; Tsuchida M; Hamawy MM
Transplant Proc; 1998 Aug; 30(5):2150-1. PubMed ID: 9723422
[No Abstract] [Full Text] [Related]
14. In vivo T cell depletion in miniature swine using the swine CD3 immunotoxin, pCD3-CRM9.
Huang CA; Yamada K; Murphy MC; Shimizu A; Colvin RB; Neville DM; Sachs DH
Transplantation; 1999 Sep; 68(6):855-60. PubMed ID: 10515387
[TBL] [Abstract][Full Text] [Related]
15. Prolonged allograft survival through conditional and specific ablation of alloreactive T cells expressing a suicide gene.
Thomas-Vaslin V; Bellier B; Cohen JL; Boyer O; Raynal-Raschilas N; Glotz D; Klatzmann D
Transplantation; 2000 May; 69(10):2154-61. PubMed ID: 10852616
[TBL] [Abstract][Full Text] [Related]
16. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
17. Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9.
Armstrong N; Buckley P; Oberley T; Fechner J; Dong Y; Hong X; Kirk A; Neville D; Knechtle S
Transplantation; 1998 Jul; 66(1):5-13. PubMed ID: 9679815
[TBL] [Abstract][Full Text] [Related]
18. Long-term kidney graft survival by delayed T cell ablative treatment in rhesus monkeys.
Jonker M; Ringers J; Ossevoort MA; Slingerland W; van den Hout Y; Haanstra K; Wubben J; Kuhn E; Friend P; Calne R
Transplantation; 2002 Mar; 73(6):874-80. PubMed ID: 11923686
[TBL] [Abstract][Full Text] [Related]
19. Approach to withdrawal from tacrolimus in a fully allogeneic murine skin graft model.
Uchiyama H; Kong Y; Kishihara K; Sugimachi K; Nomoto K
Immunology; 1999 Jun; 97(2):294-300. PubMed ID: 10447745
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and functional analysis of T-cell recovery after anti-CD3 immunotoxin treatment for tolerance induction in rhesus macaques.
Hubbard WJ; Moore JK; Contreras JL; Smyth CA; Chen ZW; Lobashevsky AL; Nagata K; Neville DM; Thomas JM
Hum Immunol; 2001 May; 62(5):479-87. PubMed ID: 11334671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
